Literature DB >> 21916597

Developing defined culture systems for human pluripotent stem cells.

Bahram Valamehr1, Hideaki Tsutsui, Chih-Ming Ho, Hong Wu.   

Abstract

Human pluripotent stem cells hold promising potential in many therapeutics applications including regenerative medicine and drug discovery. Over the past three decades, embryonic stem cell research has illustrated that embryonic stem cells possess two important and distinct properties: the ability to continuously self-renew and the ability to differentiate into all specialized cell types. In this article, we will discuss the continuing evolution of human pluripotent stem cell culture by examining requirements needed for the maintenance of self-renewal in vitro. We will also elaborate on the future direction of the field toward generating a robust and completely defined culture system, which has brought forth collaborations amongst biologists and engineers. As human pluripotent stem cell research progresses towards identifying solutions for debilitating diseases, it will be critical to establish a defined, reproducible and scalable culture system to meet the requirements of these clinical applications.

Entities:  

Mesh:

Year:  2011        PMID: 21916597      PMCID: PMC3840946          DOI: 10.2217/rme.11.54

Source DB:  PubMed          Journal:  Regen Med        ISSN: 1746-0751            Impact factor:   3.806


  113 in total

1.  Mouse embryonic stem cells exhibit indefinite proliferative potential.

Authors:  Y Suda; M Suzuki; Y Ikawa; S Aizawa
Journal:  J Cell Physiol       Date:  1987-10       Impact factor: 6.384

2.  Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides.

Authors:  A G Smith; J K Heath; D D Donaldson; G G Wong; J Moreau; M Stahl; D Rogers
Journal:  Nature       Date:  1988-12-15       Impact factor: 49.962

3.  Actin-myosin contractility is responsible for the reduced viability of dissociated human embryonic stem cells.

Authors:  Guokai Chen; Zhonggang Hou; Daniel R Gulbranson; James A Thomson
Journal:  Cell Stem Cell       Date:  2010-08-06       Impact factor: 24.633

4.  Human embryonic stem cells express an immunogenic nonhuman sialic acid.

Authors:  Maria J Martin; Alysson Muotri; Fred Gage; Ajit Varki
Journal:  Nat Med       Date:  2005-01-30       Impact factor: 53.440

5.  Expansion of human embryonic stem cells in defined serum-free medium devoid of animal-derived products.

Authors:  Yan Li; Sandra Powell; Elisa Brunette; Jane Lebkowski; Ramkumar Mandalam
Journal:  Biotechnol Bioeng       Date:  2005-09-20       Impact factor: 4.530

6.  Neurotrophins mediate human embryonic stem cell survival.

Authors:  April D Pyle; Leslie F Lock; Peter J Donovan
Journal:  Nat Biotechnol       Date:  2006-01-29       Impact factor: 54.908

7.  Dynamic suspension culture for scalable expansion of undifferentiated human pluripotent stem cells.

Authors:  Michal Amit; Ilana Laevsky; Yael Miropolsky; Kohava Shariki; Meital Peri; Joseph Itskovitz-Eldor
Journal:  Nat Protoc       Date:  2011-04-07       Impact factor: 13.491

Review 8.  Technical challenges in using human induced pluripotent stem cells to model disease.

Authors:  Krishanu Saha; Rudolf Jaenisch
Journal:  Cell Stem Cell       Date:  2009-12-04       Impact factor: 24.633

9.  Heparin promotes the growth of human embryonic stem cells in a defined serum-free medium.

Authors:  Miho K Furue; Jie Na; Jamie P Jackson; Tetsuji Okamoto; Mark Jones; Duncan Baker; Ryu-Ichiro Hata; Harry D Moore; J Denry Sato; Peter W Andrews
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-25       Impact factor: 11.205

Review 10.  Derivation of GMP raw materials for use in regenerative medicine: hESC-based therapies, progress toward clinical application.

Authors:  Z A Hewitt; K J Amps; H D Moore
Journal:  Clin Pharmacol Ther       Date:  2007-08-08       Impact factor: 6.875

View more
  12 in total

1.  Derivation and propagation of human embryonic stem cell lines from frozen embryos in an animal product-free environment.

Authors:  Emma Stephenson; Laureen Jacquet; Cristian Miere; Victoria Wood; Neli Kadeva; Glenda Cornwell; Stefano Codognotto; Yaser Dajani; Peter Braude; Dusko Ilic
Journal:  Nat Protoc       Date:  2012-06-21       Impact factor: 13.491

Review 2.  Small molecules, big roles -- the chemical manipulation of stem cell fate and somatic cell reprogramming.

Authors:  Yu Zhang; Wenlin Li; Timothy Laurent; Sheng Ding
Journal:  J Cell Sci       Date:  2012-12-01       Impact factor: 5.285

3.  Surface coating materials regulates the attachment and differentiation of mouse embryonic stem cell derived embryoid bodies into mesoderm at culture conditions.

Authors:  Derya Sağraç; Selinay Şenkal; Taha Bartu Hayal; Fikrettin Şahin; Zehra Çobandede; Ayşegül Doğan
Journal:  Cytotechnology       Date:  2022-02-22       Impact factor: 2.058

4.  Output-driven feedback system control platform optimizes combinatorial therapy of tuberculosis using a macrophage cell culture model.

Authors:  Aleidy Silva; Bai-Yu Lee; Daniel L Clemens; Theodore Kee; Xianting Ding; Chih-Ming Ho; Marcus A Horwitz
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-28       Impact factor: 11.205

5.  Efficient generation of functional epithelial and epidermal cells from human pluripotent stem cells under defined conditions.

Authors:  Joshua A Selekman; Nicholas J Grundl; Joshua M Kolz; Sean P Palecek
Journal:  Tissue Eng Part C Methods       Date:  2013-06-04       Impact factor: 3.056

Review 6.  Production of human pluripotent stem cell therapeutics under defined xeno-free conditions: progress and challenges.

Authors:  Yongjia Fan; Jincheng Wu; Preeti Ashok; Michael Hsiung; Emmanuel S Tzanakakis
Journal:  Stem Cell Rev Rep       Date:  2015-02       Impact factor: 5.739

Review 7.  Efficient and scalable expansion of human pluripotent stem cells under clinically compliant settings: a view in 2013.

Authors:  Ying Wang; Linzhao Cheng; Sharon Gerecht
Journal:  Ann Biomed Eng       Date:  2013-10-17       Impact factor: 3.934

8.  A novel platform to enable the high-throughput derivation and characterization of feeder-free human iPSCs.

Authors:  Bahram Valamehr; Ramzey Abujarour; Megan Robinson; Thuy Le; David Robbins; Daniel Shoemaker; Peter Flynn
Journal:  Sci Rep       Date:  2012-01-06       Impact factor: 4.379

9.  Platform for induction and maintenance of transgene-free hiPSCs resembling ground state pluripotent stem cells.

Authors:  Bahram Valamehr; Megan Robinson; Ramzey Abujarour; Betsy Rezner; Florin Vranceanu; Thuy Le; Amanda Medcalf; Tom Tong Lee; Michael Fitch; David Robbins; Peter Flynn
Journal:  Stem Cell Reports       Date:  2014-03-06       Impact factor: 7.765

10.  Optimized surface markers for the prospective isolation of high-quality hiPSCs using flow cytometry selection.

Authors:  Ramzey Abujarour; Bahram Valamehr; Megan Robinson; Betsy Rezner; Florin Vranceanu; Peter Flynn
Journal:  Sci Rep       Date:  2013-01-31       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.